Future Medicine Co., Ltd. (XKON:341170)
South Korea · Delayed Price · Currency is KRW 29.00
+12.00 (70.59%)
At close: Oct 2, 2026
Future Medicine Market Cap
Future Medicine has a market cap or net worth of 305.46 million as of October 2, 2026. Its market cap has decreased by -97.73% in one year.
Market Cap
305.46M
Enterprise Value
n/a
Revenue
1.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.00
ChartMarket Cap Chart
Since July 27, 2022, Future Medicine's market cap has decreased from 89.97B to 305.46M, a decrease of -99.66%. That is a compound annual growth rate of -74.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 305.46M | -98.94% |
| Dec 30, 2025 | 28.75B | 144.48% |
| Dec 30, 2024 | 11.76B | -81.54% |
| Dec 28, 2023 | 63.72B | 34.97% |
| Dec 29, 2022 | 47.21B | -47.53% |
| Jul 27, 2022 | 89.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 24.53B |
| Seoul Pharma | 22.61B |
| Daesung Microbiological Labs. | 22.57B |
| BIFIDO | 21.68B |
| Hurum | 20.40B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 18.65B |
| CXI Healthcare Technology Group | 17.34B |